Graduate Division of Biological and Biomedical Sciences: Immunology and Molecular Pathogenesis

New research from Emory University provides insight into reduced COVID-19 vaccine efficacy in lupus patients

Nasal swab tests predict COVID-19 disease severity, Emory study finds

New discovery could change autoimmune therapy landscape, study suggests

Emory researchers help discover source of deadly fungal infections in bone marrow transplant patients

Emory partners with University of Queensland to establish a cutting-edge vaccine center

Emory announces $100,000 Max Cooper Prize in Immunology

Seeking the ‘Achilles heel’ within SARS-CoV-2

School of Medicine researcher awarded $1.25 million grant to study immune response to cancer

Outstanding researchers Stevens and Silvestri honored with Albert E. Levy Award

Researchers seek to understand why vaccine responses vary from person to person

Emory scientists part of global team tracking SARS-CoV-2 variant immunology

We’re thinking about endemicity all wrong

Scientists identify obesity-promoting metabolite from intestinal bacteria

Emory ranks among top universities by Wall Street Journal/Times Higher Education

Emory team awarded $3 million to investigate lupus in African Americans

A cure for HIV: Emory receives $23.8 million NIH grant to accelerate research

Immunotherapy for HPV+ head and neck cancer: awakening the force within

NIAID grants $11 million to Emory to investigate stealthy antibiotic resistance

How two SARS-CoV-2 variants affect antibodies from vaccines

Emory-developed COVID-19 vaccine safe, effective in animal models

NCI awarding Emory $9.9 million to study cancer, autoimmune intersection with COVID-19